recurrent brain cancer
Showing 1 - 25 of >10,000
Recurrent Glioblastoma Trial in Portland (TVI-Brain 1)
Available
- Recurrent Glioblastoma
- TVI-Brain 1
-
Portland, OregonProvidence St. Vincent Medical Center
Jun 28, 2023
NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)
Not yet recruiting
- Non-small Cell Lung Cancer
- +32 more
- (no location specified)
Mar 30, 2023
Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)
Recruiting
- Glioma
- +7 more
- Laparoscopically harvested omental tissue autograft
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 31, 2023
Brain Cancer, Glioblastoma, Metastatic Cancer Trial in New York (Trastuzumab deruxtecan)
Recruiting
- Brain Cancer
- +4 more
- Trastuzumab deruxtecan
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 22, 2023
Recurrent Glioblastoma Trial in Houston (Pembrolizumab, Exablate MRgFUS + neoadjuvant pembolizumab)
Not yet recruiting
- Recurrent Glioblastoma
- Pembrolizumab
- Exablate MRgFUS + neoadjuvant pembolizumab
-
Houston, TexasM D Anderson Cancer Center
May 18, 2023
Brain Metastases, Glioma of Brain, Brain Tumor Trial in Los Angeles (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,
Recruiting
- Brain Metastases
- +3 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- Bevacizumab Injection
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 12, 2022
Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Memphis (Prexasertib, Cyclophosphamide, Gemcitabine)
Active, not recruiting
- Brain Tumor
- +12 more
- Prexasertib
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 20, 2022
Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,
Not yet recruiting
- Recurrent Glioblastoma, IDH-Wildtype
- +2 more
- Biospecimen Collection
- +2 more
- (no location specified)
May 13, 2023
Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +
Recruiting
- Melanoma
- +14 more
- LITT + Pembrolizumab
-
Gainesville, Florida
- +1 more
Aug 22, 2022
Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain, Gliosarcoma of Brain Trial in Birmingham (C134)
Active, not recruiting
- Glioblastoma Multiforme of Brain
- +2 more
- C134
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Sep 19, 2022
Brain Tumor, Cancer Trial run by the National Cancer Institute (NCI) (Zotiraciclib)
Not yet recruiting
- Brain Tumor
- Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Recurrent Brain Tumor Trial in Houston (biological, other, radiation)
Active, not recruiting
- Recurrent Brain Neoplasm
- Bevacizumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Recurrent Brain Metastases, Progressive Brain Metastases Trial in United States (Meclofenamate)
Active, not recruiting
- Recurrent Brain Metastases
- Progressive Brain Metastases
-
Miami, Florida
- +6 more
May 4, 2022
Brain Tumor, Recurrent, Brain Tumor, Pediatric, CNS Tumors Trial in Houston (RRx-001, Temozolomide, Irinotecan)
Recruiting
- Brain Tumor, Recurrent
- +3 more
- RRx-001
- +2 more
-
Houston, TexasTexas Children's Cancer Center
Aug 15, 2022
Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial
Recruiting
- Glioblastoma
- +8 more
- Intra-arterial Cetuximab
- +2 more
-
New York, New YorkLenox Hill Brain Tumor Center
Oct 17, 2022
Brain and CNS Tumors Trial in Chicago (thalidomide, topotecan HCl)
Terminated
- Brain and Central Nervous System Tumors
- thalidomide
- topotecan hydrochloride
-
Chicago, IllinoisRush Cancer Institute at Rush University Medical Center
Jan 5, 2023
Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)
Active, not recruiting
- Brain Tumor, Recurrent
- +4 more
- Cytoreductive surgery
- +2 more
-
New York, New York
- +1 more
Jun 9, 2022
Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester
Active, not recruiting
- Childhood Astrocytoma
- +9 more
- Laboratory Biomarker Analysis
- +2 more
-
Rochester, MinnesotaMayo Clinic
Sep 8, 2022
Brain Tumor, Medulloblastoma, Brain Metastases Trial in Atlanta (WP1066)
Recruiting
- Brain Tumor
- +2 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta (CHOA)
Jul 24, 2022
Glioblastoma, Brain Tumor, Glioma Trial in United States (Procedure: LITT, Hypo-Fractionated Radiation Therapy)
Recruiting
- Glioblastoma
- +3 more
- Procedure: LITT
- Hypo-Fractionated Radiation Therapy
-
Baltimore, Maryland
- +3 more
Oct 10, 2022
Patients With Brain Tumors Undergoing Surgery
Recruiting
- Central Nervous System Neoplasm
- +3 more
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Rochester, MinnesotaMayo Clinic in Rochester
Sep 29, 2022
Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte
Recruiting
- Malignant Neoplasm
- +4 more
- Chimeric Antigen Receptor T-Cell Therapy
-
Duarte, CaliforniaCity of Hope Medical Center
Sep 14, 2022
Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and
Recruiting
- Malignant Glioma of Brain
- +8 more
- Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
-
Detroit, MichiganHenry Ford Health System
Jan 9, 2023
Recurrent GBM Trial (SONALA-001 (ALA) and Exablate device)
Recruiting
- Recurrent GBM
- SONALA-001 (ALA) and Exablate device
-
Phoenix, Arizona
- +2 more
Jan 6, 2023